...
首页> 外文期刊>Nature Communications >Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs
【24h】

Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs

机译:Pancancer建模预测体细胞突变对转录程序的上下文特定影响

获取原文

摘要

Pancancer studies have identified many genes that are frequently somatically altered across multiple tumour types, suggesting that pathway-targeted therapies can be deployed across diverse cancers. However, the same ‘actionable mutation’ impacts distinct context-specific gene regulatory programs and signalling networks—and interacts with different genetic backgrounds of co-occurring alterations—in different cancers. Here we apply a computational strategy for integrating parallel (phospho)proteomic and mRNA sequencing data across 12 TCGA tumour data sets to interpret the context-specific impact of somatic alterations in terms of functional signatures such as (phospho)protein and transcription factor (TF) activities. Our analysis predicts distinct dysregulated transcriptional regulators downstream of somatic alterations in different cancers, and we validate the context-specific differential activity of TFs associated to mutant PIK3CA in isogenic cancer cell line models. These results have implications for the pancancer use of targeted drugs and potentially for the design of combination therapies.
机译:Pancancer研究已经发现许多基因在多种肿瘤类型中经常发生体细胞变化,这表明靶向途径的疗法可用于多种癌症。但是,同一“可操作的突变”会影响不同癌症中不同的特定于上下文的基因调节程序和信号网络,并与共同发生变化的不同遗传背景相互作用。在这里,我们应用了一种计算策略,用于整合12个TCGA肿瘤数据集上的并行(磷酸)蛋白质组学和mRNA测序数据,以从功能标记(如(磷酸)蛋白和转录因子(TF))的角度解释体细胞改变的背景特定影响活动。我们的分析预测了不同癌症中体细胞变化下游的异常失调的转录调节子,并且我们在同基因癌细胞系模型中验证了与突变体PIK3CA相关的TF的背景特异性差异活性。这些结果对靶向药物的全癌使用以及对联合疗法的设计有潜在影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号